Product Pipeline

In addition to Twirla, we are developing a pipeline of other new transdermal contraceptive products, including:

  • AG200-SP, a regimen designed to allow women to experience shorter, lighter periods
  • AG200-ER, a regimen designed to allow a woman to extend the length of her cycle
  • AG200-ER (SmP), a regimen designed to allow a woman to extend the length of her cycle and experience shorter, lighter periods
  • AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen